Executive Medical Director, (Retina Program)
Core
Lead clinical development and execution of Phase 1 retina trials for late-stage biotech therapeutics targeting wet age-related macular degeneration and diabetic macular edema.
Role type
Senior IC clinical lead (ophthalmology/retina)
Builds
Phase 1 clinical trials for gene therapy and anti-VEGF treatments
Domain
Biotechnology / Ophthalmology / Retina
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Medical degree (M.D.), Ophthalmology residency, Retina subspecialty training, Board certification, Phase 1 clinical trial leadership, Medical monitoring, Gene therapy study experience, Regulatory document authoring (INDs, IBs, CSRs), Biomarker strategy development, Cross-functional team leadership
Preferred skills
Phase 2/3 clinical research experience, NDA/BLA/MAA submission planning, Data analysis and interpretation, Public speaking
Technologies
Anti-VEGF therapies, Gene therapy, CFTR transgene delivery
Responsibilities
Design and execute Phase 1 retina clinical trials; Serve as medical monitor ensuring subject safety and data integrity; Lead cross-functional study teams; Develop and implement biomarker strategies; Author regulatory documents and lead IND submissions; Organize scientific advisory board meetings.
Seniority
Senior, hands-on IC
